Literature DB >> 22688490

Ketoacidosis in type 2 diabetes--is it type 1 and 1/2 diabetes?

Debbie Gooderick1, Umesh Dashora, Sathis Kumar.   

Abstract

A 64-year-old female with a background of type 2 diabetes became acutely unwell after being transferred from insulin to liraglutide, which is one of the new glucagon like peptide 1 analogues. On assessment in accident and emergency, she was diagnosed with diabetic ketoacidosis and pancreatits. Glutamic acid decarboxylase antibodies were positive at 45 (0-1 U/ml) and C-peptide was low <94 pmol/l in keeping with the diagnosis of latent autoimmune diabetes of adults (LADA). This type of diabetes is characterised by slow autoimmune destruction of β cells of pancreas and can often be mistaken for type 2 diabetes. Patients suffering from LADA or type 1 and 1/2 diabetes require insulin to prevent ketoacidosis. She recovered with insulin treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22688490      PMCID: PMC3158345          DOI: 10.1136/bcr.07.2011.4460

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

Authors:  H Borg; A Gottsäter; M Landin-Olsson; P Fernlund; G Sundkvist
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

2.  Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

Authors:  Mary Parks; Curtis Rosebraugh
Journal:  N Engl J Med       Date:  2010-02-17       Impact factor: 91.245

3.  GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.

Authors:  L K Niskanen; T Tuomi; J Karjalainen; L C Groop; M I Uusitupa
Journal:  Diabetes Care       Date:  1995-12       Impact factor: 19.112

4.  Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA.

Authors:  S Nair; D Yadav; C S Pitchumoni
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

5.  Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.

Authors:  M Landin-Olsson; K O Nilsson; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

6.  Latent autoimmune diabetes in adults.

Authors:  Mona Landin-Olsson
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

7.  Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study.

Authors:  S Carlsson; K Midthjell; M Y Tesfamarian; V Grill
Journal:  Diabetologia       Date:  2006-11-10       Impact factor: 10.122

8.  Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.

Authors:  T Tuomi; L C Groop; P Z Zimmet; M J Rowley; W Knowles; I R Mackay
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

  8 in total
  3 in total

1.  Severe Ketoacidosis (pH ≤ 6.9) in Type 2 Diabetes: More Frequent and Less Ominous Than Previously Thought.

Authors:  René Rodríguez-Gutiérrez; Carlos R Cámara-Lemarroy; Dania L Quintanilla-Flores; Emanuel I González-Moreno; Juan Manuel González-Chávez; Fernando Javier Lavalle-González; Jose Gerardo González-González; A Enrique Caballero
Journal:  Biomed Res Int       Date:  2015-06-21       Impact factor: 3.411

2.  Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus.

Authors:  Zaynab Alourfi; Hakam Homsi
Journal:  Avicenna J Med       Date:  2015 Jan-Mar

3.  Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial.

Authors:  Yasuyo Ando; Fumika Shigiyama; Takahisa Hirose; Naoki Kumashiro
Journal:  J Diabetes Investig       Date:  2021-03-18       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.